Loading company…
PureIMS develops dry-powder inhalers for delivering medicines to treat respiratory and systemic diseases.
PureIMS develops dry-powder inhalers for rapid, controlled drug delivery. Its pipeline includes products for Parkinson’s disease, severe allergic reactions, cystic fibrosis, bronchiectasis, and tuberculosis. Founded in 2014, the company is based in Drenthe, Netherlands. It raised funding from Boost-UP Foundation in April 2023 to develop Levodopa Cyclops™ for US and EEA marketing.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in